Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
aspirin,clopidogrel hydrogen sulfate
Apotex Pty Ltd
Aspirin,clopidogrel hydrogen sulfate
Registered
APO-CLOPIDOGREL/ ASPIRIN FILM COATED TABLETS _clopidogrel (as clopidogrel hydrogen sulfate) and aspirin_ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055_ WHAT IS IN THIS LEAFLET READ THIS LEAFLET CAREFULLY BEFORE TAKING YOUR MEDICINE. This leaflet answers some common questions about Clopidogrel/Aspirin. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. Keep this leaflet with your medicine. You may want to read it again. WHAT THIS MEDICINE IS USED FOR The name of your medicine is APO- Clopidogrel/Aspirin. It contains the active ingredients clopidogrel (as clopidogrel hydrogen sulfate) and aspirin. Clopidogrel/Aspirin is used to prevent blood clots forming in hardened blood vessels (a process known as atherothrombosis), which can lead to events such as stroke, heart attack or death. Clopidogrel/Aspirin belongs to a group of medicines called anti- platelet medicines. Platelets are very small blood cells which clump together during blood clotting. By preventing this clumping, anti-platelet medicines reduce the chances of blood clots forming (a process called thrombosis). You may have been prescribed clopidogrel/aspirin to help prevent blood clots forming and to reduce the risk of heart attack, stroke or death, because you have suffered a severe type of chest pain called unstable angina or have had a heart attack. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. This medicine is available only with a doctor's prescription. There is no evidence that this medicine is addictive. BEFORE YOU TAKE THIS MEDICINE _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE THIS MEDICINE IF YOU HAVE Read the complete document
1 AUSTRALIAN PRODUCT INFORMATION APO- CLOPIDOGREL/ASPIRIN (CLOPIDOGREL HYDROGEN SULFATE/ASPIRIN) FILM COATED TABLETS 1 NAME OF THE MEDICINE Clopidogrel (as clopidogrel hydrogen sulfate) and Aspirin (acetylsalicylic acid). 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet of APO-Clopidogrel/Aspirin 75/75 contains 75 mg clopidogrel (as clopidogrel hydrogen sulfate) and 75 mg aspirin. Each tablet of APO- Clopidogrel/Aspirin 75/100 contains 75 mg clopidogrel (as clopidogrel hydrogen sulfate) and 100 mg aspirin. EXCIPIENTS WITH KNOWN EFFECT Lactose For the full list of excipients see section 6.1 LIST OF EXCIPIENTS 3 PHARMACEUTICAL FORM APO-Clopidogrel/Aspirin 75/75 tablets: Yellow, oval, biconvex coated tablet. Engraved “75-75” on one side, “APO” on the other side. APO- Clopidogrel/Aspirin 75/100 Tablets: Light pink, oval biconvex coated tablets, engraved “APO” on one side, “75-100” on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clopidogrel/Aspirin is a fixed-dose combination product. Clopidogrel/Aspirin is intended as continuation of therapy in patients with acute coronary syndrome already initiated with separate clopidogrel and aspirin products: • Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel/Aspirin is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent). • ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, Clopidogrel/Aspirin has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy. 4.2 DOSE AND METHOD OF ADMINISTRATION APO- Clopidogrel/Aspirin tablets are intended for oral administration. 2 DOSAGE ADULTS Clopidogre Read the complete document